Gary Pace - Sep 15, 2022 Form 4 Insider Report for Cardiff Oncology, Inc. (CRDF)

Role
Director
Signature
/s/ Gary Pace
Stock symbol
CRDF
Transactions as of
Sep 15, 2022
Transactions value $
$256,500
Form type
4
Date filed
9/19/2022, 08:37 AM
Previous filing
Jun 8, 2022
Next filing
May 15, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRDF Common Stock Purchase $257K +150K +30.31% $1.71 645K Sep 15, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.65 to $1.78. Full information regarding the number of shares purcahsed at each separate price can be furnished to the SEC staff upon request.